cd 437 has been researched along with Cancer of Prostate in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chung, LW; Jin, F; Khuri, FR; Liu, X; Lotan, R; Sun, SY; Yue, P; Zhou, Z | 1 |
Dawson, MI; Feng, P; Fontana, JA; Liang, JY; Ordonez, JV; Rao, JN; Shroot, B; Wilber, JF | 1 |
Lotan, R; Sun, SY; Yue, P | 1 |
Dawson, M; Fang, G; Farhana, L; Fontana, JA; Kirschner, MW; Reichert, U; Rishi, AK; Trivedi, C; Van Buren, E; Zhang, Y | 1 |
4 other study(ies) available for cd 437 and Cancer of Prostate
Article | Year |
---|---|
Activation of nuclear factor-kappaB contributes to induction of death receptors and apoptosis by the synthetic retinoid CD437 in DU145 human prostate cancer cells.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 8; Caspases; Cell Line, Tumor; Humans; I-kappa B Proteins; Male; NF-kappa B; NF-KappaB Inhibitor alpha; Prostatic Neoplasms; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; Retinoids; Sesquiterpenes; Sesquiterpenes, Guaiane; Up-Regulation | 2005 |
Synthetic retinoid CD437 induces S-phase arrest and apoptosis in human prostate cancer cells LNCaP and PC-3.
Topics: Antineoplastic Agents; Apoptosis; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Enzyme Inhibitors; Humans; Male; Prostatic Neoplasms; Retinoids; S Phase; Tumor Cells, Cultured | 1999 |
Implication of multiple mechanisms in apoptosis induced by the synthetic retinoid CD437 in human prostate carcinoma cells.
Topics: Androgens; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Carcinoma; Caspase 3; Caspases; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Fas Ligand Protein; fas Receptor; Gene Expression Regulation, Neoplastic; Humans; Male; Membrane Glycoproteins; Oncogenes; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; Retinoids; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53 | 2000 |
Cyclin B and E2F-1 expression in prostate carcinoma cells treated with the novel retinoid CD437 are regulated by the ubiquitin-mediated pathway.
Topics: Acetylation; Antineoplastic Agents; Apoptosis; Cell Cycle Proteins; Consensus Sequence; Cyclin B; DNA-Binding Proteins; E2F Transcription Factors; E2F1 Transcription Factor; Humans; Male; Prostatic Neoplasms; Retinoids; S Phase; S-Phase Kinase-Associated Proteins; Transcription Factors; Tumor Cells, Cultured; Ubiquitin | 2002 |